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Malignant fibrous histiocytoma (MFH) is the most
common malignant soft tissue tumor in older adults,
most frequently involving the extremities, retro-
peritoneum, and trunk, but it is rare as a primary
tumor of the lung [1–3]. Chest roentgenography, chest
computerized tomography (CT), and magnetic reso-
nance imaging (MRI) disclose a well-defined mass
shadow that is not very lobulated [3–5]. Early diagnosis
is very important because of the poor prognosis.
Bronchoscopy and percutaneous needle aspiration are
of limited value in differential diagnosis, and
thoracotomy is warranted for definitive diagnosis
[2,6]. Surgery is the primary mode of therapy [7].
We report a case of primary MFH of the lung
illustrating the clinical, radiologic, histologic,
immunohistochemical, and ultrastructural features,
and the difficulty in treating such cases.
CASE PRESENTATION
An 86-year-old male was admitted to our hospital in
February 2002 due to insidious onset of exertional
dyspnea and poor appetite lasting for 1 month. He had
previously been quite well and had no history of
smoking. Physical examination revealed pale
conjunctivae and decreased breath sounds over the
left basal lung field. Laboratory examinations showed
mild anemia, hyponatremia, hypoalbuminemia, and a
high C-reactive protein concentration. Tumor markers,
including carcinoembryonic antigen, tissue plasmin
antigen, and squamous cell carcinoma antigen, were
within normal limits.  Chest roentgenography
demonstrated a 9 × 15 cm, pleural-based opacity in the
left lower lobe (Figure 1). Chest CT revealed a well-
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defined mass with heterogeneous density in the left
lower lung field. Local extension to the left chest wall
and right pleural effusion were noted (Figure 2).
Gallium whole-body scan revealed intensively
increased radioactivity in the anterolateral aspect of
the left lower chest with a photopenic area in the
adjacent middle portion and gradually increasing
contrast throughout the serial 6-, 24- and 48-hour
images.
Thoracoscopic lung biopsy yielded eight tissue
fragments, measuring up to 1.8 × 1.1 × 0.8 cm. Grossly,
they were reddish, soft and elastic, or whitish, soft and
jelly-like. A storiform pattern of spindle cells and
multinucleated giant cancer cells with atypical mitotic
figures were seen on microscopy (Figures 3 and 4).
Hemorrhage and necrosis were noted. Immuno-
histochemical studies were negative for cytokeratin,
CK5/6, and calretinin, but positive for vimentin.
Therefore, MFH was diagnosed. Because the patient
was extremely old in age and had poor performance
status (Karnofsky performance status = 30), he received
supportive care. He died in April 2002 from respiratory
failure.
DISCUSSION
MFH is the most common (10%) soft tissue sarcoma in
adults and mostly occurs in males. It mainly arises
from soft tissue in the extremities (68%), the
retroperitoneum (16%), and lung (7.5%) [1]. Primary
MFH comprises 0.04% of all pulmonary malignant
tumors [2]. There must be no evidence of another
primary site on careful physical examination and
radiologic evaluation before MFH can be considered a
primary rather than a metastatic lesion. The mean age
of patients with primary lung MFH is 55 years (range,
10–80 years) [7,8]. There are no predisposing factors.
The most common complaints are cough, dyspnea,
fatigue, hemoptysis, weakness, headache, fever, chills,
weight loss, and chest pain. Patients may be asymp-
tomatic at presentation [7,9–11]. Our patient was older
than usual (86 years old), and his initial presentation
was exertional dyspnea and poor appetite.
Typically, lung MFH appears as a large, solitary,
well-circumscribed, non-cavitating, non-calcified,
peripheral lung mass with a slight preponderance in
the middle and lower lobes. Approximately 20% of
patients have associated pleural effusion [3,4]. CT and
Figure 1. Chest roentgenography shows a 9 × 15 cm, pleural-
based opacity in the left lower lobe.
Figure 2. Chest computerized tomography reveals a well-defined
mass with heterogeneous density in the left lower lung field. Local
extension to the left chest wall and right pleural effusion are
evident.
MRI can provide useful information to demonstrate
the nature and extent of tumor invasion [5]. On CT,
lung MFH appears to be of soft-tissue density,
sometimes with central areas of low attenuation. The
tumor displaces rather than invades local structures.
In our case, imaging showed a huge, well-defined
tumor in the left lower lobe with soft-tissue density
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the storiform variety. No definite relationship between
survival and histology has been identified because of
the predominance of the storiform subtype. The most
significant prognostic factors are the presence of
metastases, local recurrence, and more than 15%
necrosis [13]. In our case, histology revealed a storiform
pattern in spindle cells and multinucleated giant cells.
Hemorrhage and necrosis were noted. Immuno-
histochemical studies were negative for cytokeratin,
CK5/6, and calretinin, but positive for vimentin.
Bronchoscopy and percutaneous needle aspiration
are of limited value in differential diagnosis, and
thoracotomy is warranted for definitive diagnosis
[2,6]. Mediastinoscopy is not useful because MFH
usually disseminates hematogenously and does not
commonly invade lymphatics [2,12]. The brain is a
common site of metastasis [9,14–17].
Complete tumor resection is the treatment of choice,
with high rates of local and distant recurrence reported.
The roles of radiation and chemotherapy have not
been clearly defined [7]. Systemic chemotherapy has
been used largely for metastatic disease, but has yielded
poor results [7,15,18,19]. In our case, the patient only
received supportive care due to his extreme old age
and poor performance status.
In conclusion, MFH of the lung is a rare clinical
entity with variable outcome. Aggressive surgery is
the mainstay of treatment. The role of adjuvant
radiation and chemotherapy remains undefined.
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